LifeLinc Anesthesia competitors

I am an aspiring sports broadcaster from Pembroke, Massachusetts. As a dedicated and hard-working leader, success is something I pride myself on. Thus, going above and beyond the bare minimum is something I strive for constantly. From the moment I stepped on campus at Quinnipiac University, I understood how extra curricular activities were the key to success. Therefore, I quickly joined student media organizations and gained extensive knowledge from the start. I now have two years experience in a student-run news room. Editing and shooting video, writing for print and for broadcast, play by play and color commentary, and control room operations are all skills I have gained from my hands on experience outside of the classroom.

Julie Faling is a Chief Executive Officer at HCFS and is based in Frisco, Texas. She studied at Oklahoma State University between 1982 and 1985.

Greg Nulty is the Chief Financial Officer at Performance Health, a leader in consumer healthcare and the largest global manufacturer and distributor of products to the physical therapy, sports medicine, and rehabilitation markets. Greg has spent the past 16 years with Novartis Group, most recently serving as CFO of Sandoz’s nearly $4 billion North America business in Princeton, NJ since 2016. Prior to this, Greg was the head of Business Planning and Analysis for Sandoz globally from 2013 - 2016 in Munich, Germany, and between 2011 and 2013, he served as CFO of Sandoz’s Asia Pacific based in Singapore. Prior to this, Greg served as head of Business Planning and Analysis globally at Novartis’s Consumer Health division from 2009- 2011, after serving as CFO of Western Europe for Sandoz from 2005-2007. Greg began his career with Novartis as a senior controller. Prior to joining Novartis, he worked in corporate finance with Andersen and as an Auditor with Ernst & Young, both in his native South Africa, as well as with Merrill Lynch in London. Greg received his MBA from INSEAD and holds a Bachelor’s degree in Commerce from the University of Cape Town, where he graduated with high distinction.

John T. Spitznagel is a Chief Executive Officer at NovaSom Inc and is based in Auburn, New York.

John Driscoll brings more than 25 years of health care experience to CareCentrix. Prior to CareCentrix, John served as President at Castlight Health, a healthcare technology company. Previously, John served as Group President for new markets at Medco (a $70 billion Pharmacy Benefit Manager). He led product development for employer and health plan clients. During his years at Medco, John was part of the senior management team that spun Medco out of Merck, building an enterprise that was named as the most admired company in healthcare services by Fortune. He was responsible for Medco’s entry into Medicare, growing the business from start-up to $20 billion in annual revenue. John also led Medco’s acquisitions and investments, investing over $10 billion in capital in high-growth companies, including specialty pharmacy Accredo Health. During John’s tenure, he was also in charge of Retail network contracting, Medco’s data products, Medco International, and Medco’s specialty pharmacy business. John founded and chaired the Surescripts ePrescribing Network, building the first cross-industry collaborative with competing Retail, PBM, and Health Plans cooperating to revolutionize e-prescribing. Surescripts has grown from servicing under 50 million prescriptions in 2005, to over 1 billion prescriptions today. John also served as an Advisor to Oak Investment Partners. He was a member of the executive team at Oxford Health Plans, serving as Corporate Vice President for government programs. At Oxford Health Plans, he built and led the Medicare & Medicaid business, from start-up to over $1.3 billion in annual revenue. During his time at Oxford, the company was one of the fastest growing companies in the U.S. and was widely recognized as one of the most innovative companies in healthcare. John was selected by the White House for its Entrepreneurs in Residence program in 2011 to advise the FDA on new paths for innovation. He has published articles in Los Angeles Times and Time Magazine. John has a B.A. and M.B.A. from Harvard University, and was a resident tutor at Winthrop House. John also holds an MPhil from Cambridge University in England. He chairs the Truman National Security Project, and served as a captain in the U.S. Army Reserve. He serves as a Board Member for the Alliance for Hunger and the Press Ganey Corporation, and previously served on the Board of Outward Bound, Hurricane Island Outward Bound School, and the Domus Foundation.

George Abatjoglou is Chief Executive Officer at Kemberton Healthcare Services. He attended Miami University.